Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cachexia × Atenolol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma, Capillary 2 Weight Loss 1 Spinal Cord Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Hemangioma 1 Cachexia 1

Interventions

Megestrol Acetate 9 Exercise 6 Standard of Care 4 Blood Specimen Collection 4 Olanzapine 3 Ibuprofen 3 dermcidin 2 anamorelin 2 Resistance Training 2 Physical Therapy Modalities 2 Nutrition Assessment 2 Mirtazapine 2 Melatonin 2 Infliximab 2 Enteral Nutrition 2 Dietary Supplements 2 Diet Therapy 2 Cyproheptadine 2 testosterone enanthate 1 telotristat ethyl 1 remune 1 ostarine 1 olanzapine-fluoxetine combination 1 nabiximols 1 nabilone 1 irinotecan sucrosofate 1 fucoidan 1 clazakizumab 1 bermekimab 1 alkaloid GB18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00625742 2016-02-12

Multimodal Treatment Strategy for Cancer Cachexia

M.D. Anderson Cancer Center

Phase NA Terminated

15 enrolled 4 charts

Cachexia, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡